Compugen Ltd (CGEN) stock
CGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$2.10−0.02 (-0.94%)
Close on Nov 13, 2026Market cap $198.56MP/E 5.5Yield –
Compugen cash
Cash and short-term investments held at the end of each period.
Compugen's cash was $49.96M at Jun 30, 2026. For fiscal 2025 it was $99.88M, up 138.6% from the year before. Over ten years it grew 23.3% a year on average. The highest annual figure on record is $99.88M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $99.88M | +138.6% |
| FY2024 | Dec 31, 2024 | $41.86M | +63.3% |
| FY2023 | Dec 31, 2023 | $25.63M | +124.4% |
| FY2022 | Dec 31, 2022 | $11.42M | +34.1% |
| FY2021 | Dec 31, 2021 | $8.51M | +9.0% |
| FY2020 | Dec 31, 2020 | $7.81M | -20.6% |
| FY2019 | Dec 31, 2019 | $9.84M | +52.2% |
| FY2018 | Dec 31, 2018 | $6.47M | -75.6% |
| FY2017 | Dec 31, 2017 | $26.52M | +147.8% |
| FY2016 | Dec 31, 2016 | $10.70M | -12.9% |
| FY2015 | Dec 31, 2015 | $12.28M | -54.9% |
| FY2014 | Dec 31, 2014 | $27.24M | -5.3% |
| FY2013 | Dec 31, 2013 | $28.75M | +75.6% |
| FY2012 | Dec 31, 2012 | $16.37M | +180.1% |
| FY2011 | Dec 31, 2011 | $5.85M | -19.9% |
| FY2010 | Dec 31, 2010 | $7.30M | -51.8% |
| FY2009 | Dec 31, 2009 | $15.14M | +225.6% |
| FY2008 | Dec 31, 2008 | $4.65M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $49.96M | +12.1% |
| Q4 FY2025 | Dec 31, 2025 | $99.88M | +289.7% |
| Q2 FY2025 | Jun 30, 2025 | $35.34M | +58.9% |
| Q4 FY2024 | Dec 31, 2024 | $41.86M | +266.5% |
| Q2 FY2024 | Jun 30, 2024 | $44.57M | +432.4% |
| Q4 FY2023 | Dec 31, 2023 | $25.63M | +201.1% |
| Q2 FY2023 | Jun 30, 2023 | $22.24M | +160.8% |
| Q4 FY2022 | Dec 31, 2022 | $11.42M | +46.2% |
| Q2 FY2022 | Jun 30, 2022 | $8.37M | -36.1% |
| Q4 FY2021 | Dec 31, 2021 | $8.51M | -13.5% |
| Q2 FY2021 | Jun 30, 2021 | $8.53M | +36.9% |
| Q4 FY2020 | Dec 31, 2020 | $7.81M | +20.8% |
| Q2 FY2020 | Jun 30, 2020 | $13.11M | +19.8% |
| Q4 FY2019 | Dec 31, 2019 | $9.84M | -62.9% |
| Q2 FY2019 | Jun 30, 2019 | $6.23M | -65.3% |
| Q4 FY2018 | Dec 31, 2018 | $6.47M | -39.6% |
| Q2 FY2018 | Jun 30, 2018 | $10.94M | -43.7% |
| Q4 FY2017 | Dec 31, 2017 | $26.52M | +116.0% |
| Q2 FY2017 | Jun 30, 2017 | $17.96M | +87.5% |
| Q4 FY2016 | Dec 31, 2016 | $10.70M | -60.7% |
| Q2 FY2016 | Jun 30, 2016 | $19.43M | -81.2% |
| Q4 FY2015 | Dec 31, 2015 | $12.28M | -57.3% |
| Q2 FY2015 | Jun 30, 2015 | $9.58M | -26.8% |
| Q4 FY2014 | Dec 31, 2014 | $27.24M | +66.4% |
| Q2 FY2014 | Jun 30, 2014 | $103.24M | +1075.0% |
| Q4 FY2013 | Dec 31, 2013 | $28.75M | +391.8% |
| Q2 FY2013 | Jun 30, 2013 | $13.09M | +110.0% |
| Q4 FY2012 | Dec 31, 2012 | $16.37M | +124.3% |
| Q2 FY2012 | Jun 30, 2012 | $8.79M | -42.0% |
| Q4 FY2011 | Dec 31, 2011 | $5.85M | +25.7% |
| Q2 FY2011 | Jun 30, 2011 | $6.23M | – |
| Q4 FY2010 | Dec 31, 2010 | $7.30M | – |
| Q4 FY2009 | Dec 31, 2009 | $15.14M | – |
| Q4 FY2008 | Dec 31, 2008 | $4.65M | – |
See a number that looks wrong?